OXCT1-AS1

Across TCGA pan-cancer cohorts, OXCT1-AS1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of OXCT1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where OXCT1-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types OXCT1-AS1 is over-expressed in tumor, although a few such as THCA and UCEC show the opposite, repressed pattern.

THCA, UCEC, and BRCA are the cancer types where OXCT1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OXCT1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.841	<.001	9	view →
UCEC	All	All	−1.063	<.001	6	view →
BRCA	All	All	−1.045	<.001	6	view →
STAD	All	All	−0.340	.004	5	view →
BLCA	All	IV	−0.947	.002	4	view →
READ	All	All	−0.598	.001	3	view →
LUAD	All	II,III,IV	−0.182	.009	3	view →
KIRC	Male	II,III,IV	−0.396	.014	2	view →
ESCA	All	II,III,IV	−0.294	.023	2	view →
PRAD	All	All	−0.268	.002	2	view →
LUSC	All	All	+0.204	.038	1	view →
LIHC	All	All	+0.057	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

OXCT1-AS1–THCA

Open the THCA breakdown →